Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice

Human Molecular Genetics

Volumn 19, Issue 4, 2009, Pages 597-608

  Wu, Sulin ^a   Mar Heyming, Rebecca ^a   Dugum, Eric Z ^b   Kolaitis, Nicholas A ^a   Qi, Hongxiu ^a   Pajukanta, Päivi ^a   Castellani, Lawrence W ^a   Lusis, Aldons J ^a,b   Drake, Thomas A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UPSTREAM STIMULATORY FACTOR 1; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL; LIPID; UPSTREAM STIMULATORY FACTOR; USF1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; CAUSAL ATTRIBUTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MALE; METABOLIC RATE; METABOLIC SYNDROME X; METABOLISM; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; SEX DIFFERENCE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BLOOD; C3H MOUSE; C57BL MOUSE; DISEASE MODEL; FAMILIAL HYPERLIPEMIA; GENETICS; LIVER; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

ANIMALS; CHOLESTEROL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; UPSTREAM STIMULATORY FACTORS;

EID: 77950358523     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp526     Document Type: Article

References (53)

1. Genest, J.J. Jr, Martin-Munley, S.S., McNamara, J.R., Ordovas, J.M., Jenner, J., Myers, R.H., Silberman, S.R., Wilson, P.W., Salem, D.N. and Schaefer, E.J. (1992) Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation, 85, 2025-2033.
2. Goldstein, J.L., Schrott, H.G., Hazzard, W.R., Bierman, E.L. and Motulsky, A.G. (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest., 52, 1544-1568.
3. Hopkins, P.N., Heiss, G., Ellison, R.C., Province, M.A., Pankow, J.S., Eckfeldt, J.H. and Hunt, S.C. (2003) Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation, 108, 519-523.
4. Lee, J.C., Lusis, A.J. and Pajukanta, P. (2006) Familial combined hyperlipidemia: upstream transcription factor 1 and beyond. Curr. Opin. Lipidol., 17, 101-109.
5. Pajukanta, P., Nuotio, I., Terwilliger, J.D., Porkka, K.V., Ylitalo, K., Pihlajamaki, J., Suomalainen, A.J., Syvanen, A.C., Lehtimaki, T., Viikari, J.S. et al. (1998) Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat. Genet., 18, 369-373.
6. Coon, H., Eckfeldt, J.H., Leppert, M.F., Myers, R.H., Arnett, D.K., Heiss, G., Province, M.A. and Hunt, S.C. (2002) A genome-wide screen reveals evidence for a locus on chromosome 11 influencing variation in LDL cholesterol in the NHLBI Family Heart Study. Hum. Genet., 111, 263-269.
7. Allayee, H., Krass, K.L., Pajukanta, P., Cantor, R.M., van der Kallen, C.J., Mar, R., Rotter, J.I., de Bruin, T.W., Peltonen, L. and Lusis, A.J. (2002) Locus for elevated apolipoprotein B levels on chromosome 1p31 in families with familial combined hyperlipidemia. Circ. Res., 90, 926-931.
8. Pei, W., Baron, H. and Muller-Myhsok, B. (2000) Linkage of familial combined hyperlipidemia to chromosome 1q21-23 in Chinese and German families. Zhonghua Yi Xue Za Zhi, 80, 25-27.
9. Huertas-Vazquez, A., Aguilar-Salinas, C., Lusis, A.J., Cantor, R.M., Canizales-Quinteros, S., Lee, J.C., Mariana-Nunez, L., Riba-Ramirez, R.M., Jokiaho, A., Tusie-Luna, T. et al. (2005) Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arterioscler. Thromb. Vasc. Biol., 25, 1985-1991.
10. Pajukanta, P., Lilja, H.E., Sinsheimer, J.S., Cantor, R.M., Lusis, A.J., Gentile, M., Duan, X.J., Soro-Paavonen, A., Naukkarinen, J., Saarela, J. et al. (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat. Genet., 36, 371-376.
11. Ng, M.C., So, W.Y., Lam, V.K., Cockram, C.S., Bell, G.I., Cox, N.J. and Chan, J.C. (2004) Genome-wide scan for metabolic syndrome and related quantitative traits in Hong Kong Chinese and confirmation of a susceptibility locus on chromosome 1q21-q25. Diabetes, 53, 2676-2683.
12. Langefeld, C.D., Wagenknecht, L.E., Rotter, J.I., Williams, A.H., Hokanson, J.E., Saad, M.F., Bowden, D.W., Haffner, S., Norris, J.M., Rich, S.S. et al. (2004) Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study. Diabetes, 53, 1170-1174.
13. Lee, J.C., Weissglas-Volkov, D., Kyttala, M., Sinsheimer, J.S., Jokiaho, A., de Bruin, T.W., Lusis, A.J., Brennan, M.L., van Greevenbroek, M.M., van der Kallen, C.J. et al. (2007) USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease. Arterioscler. Thromb. Vasc. Biol., 27, 2222-2227.
14. Choquette, A.C., Bouchard, L., Houde, A., Bouchard, C., Perusse, L. and Vohl, M.C. (2007) Associations between USF1 gene variants and cardiovascular risk factors in the Quebec Family Study. Clin. Genet., 71, 245-253.
15. Auro, K., Kristiansson, K., Zethelius, B., Berne, C., Lannfelt, L., Taskinen, M.R., Jauhiainen, M., Perola, M., Peltonen, L. and Syvanen, A.C. (2008) USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study. Diabetologia, 51, 464-472.
16. Zeggini, E., Damcott, C.M., Hanson, R.L., Karim, M.A., Rayner, N.W., Groves, C.J., Baier, L.J., Hale, T.C., Hattersley, A.T., Hitman, G.A. et al. (2006) Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1q. Diabetes, 55, 2541-2548.
17. Holzapfel, C., Baumert, J., Grallert, H., Muller, A.M., Thorand, B., Khuseyinova, N., Herder, C., Meisinger, C., Hauner, H., Wichmann, H.E. et al. (2008) Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Eur. J. Endocrinol., 159, 407-416.
18. Meex, S.J., van Vliet-Ostaptchouk, J.V., van der Kallen, C.J., van Greevenbroek, M.M., Schalkwijk, C.G., Feskens, E.J., Blaak, E.E., Wijmenga, C., Hofker, M.H., Stehouwer, C.D. et al. (2008) Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: association study in 2000 Dutch Caucasians. Mol. Genet. Metab., 94, 352-355.
19. Collings, A., Hoyssa, S., Fan, M., Kahonen, M., Hutri-Kahonen, N., Marniemi, J., Juonala, M., Viikari, J.S., Raitakari, O.T. and Lehtimaki, T.J. (2008) Allelic variants of upstream transcription factor 1 associate with carotid artery intima-media thickness: the Cardiovascular Risk in Young Finns study. Circ. J., 72, 1158-1164.
20. Kristiansson, K., Ilveskoski, E., Lehtimaki, T., Peltonen, L., Perola, M. and Karhunen, P.J. (2008) Association analysis of allelic variants of USF1 in coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 28, 983-989.
21. Komulainen, K., Alanne, M., Auro, K., Kilpikari, R., Pajukanta, P., Saarela, J., Ellonen, P., Salminen, K., Kulathinal, S., Kuulasmaa, K. et al. (2006) Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies. PLoS Genet., 2, e69.
22. Reiner, A.P., Carlson, C.S., Jenny, N.S., Durda, J.P., Siscovick, D.S., Nickerson, D.A. and Tracy, R.P. (2007) USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies. Arterioscler. Thromb. Vasc. Biol., 27, 2736-2742.
23. Lusis, A.J., Attie, A.D. and Reue, K. (2008) Metabolic syndrome: from epidemiology to systems biology. Nat. Rev. Genet., 9, 819-830.
24. Gibson, F., Hercberg, S. and Froguel, P. (2005) Common polymorphisms in the USF1 gene are not associated with type 2 diabetes in French Caucasians. Diabetes, 54, 3040-3042.
25. Ng, M.C., Miyake, K., So, W.Y., Poon, E.W., Lam, V.K., Li, J.K., Cox, N.J., Bell, G.I. and Chan, J.C. (2005) The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population. Diabetologia, 48, 2018-2024.
26. Plaisier, C.L., Horvath, S., Huertas-Vazquez, A., Cruz-Bautista, I., Herrera, M.F., Tusie-Luna, T., Aguilar-Salinas, C. and Pajukanta, P. (2009) A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia. PLoS Genet., 5, e1000642.
27. Sirito, M., Walker, S., Lin, Q., Kozlowski, M.T., Klein, W.H. and Sawadogo, M. (1992) Members of the USF family of helix-loop-helix proteins bind DNA as homo-as well as heterodimers. Gene Expr., 2, 231-240.
28. Naukkarinen, J., Gentile, M., Soro-Paavonen, A., Saarela, J., Koistinen, H.A., Pajukanta, P., Taskinen, M.R. and Peltonen, L. (2005) USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum. Mol. Genet., 14, 2595-2605.
29. Rada-Iglesias, A., Ameur, A., Kapranov, P., Enroth, S., Komorowski, J., Gingeras, T.R. and Wadelius, C. (2008) Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders. Genome Res., 18, 380-392.
30. Sirito, M., Lin, Q., Deng, J.M., Behringer, R.R. and Sawadogo, M. (1998) Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. Proc. Natl Acad. Sci. USA, 95, 3758-3763.
31. Vallet, V.S., Casado, M., Henrion, A.A., Bucchini, D., Raymondjean, M., Kahn, A. and Vaulont, S. (1998) Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J. Biol. Chem., 273, 20175-20179.
32. Chen, Y., Zhu, J., Lum, P.Y., Yang, X., Pinto, S., MacNeil, D.J., Zhang, C., Lamb, J., Edwards, S., Sieberts, S.K. et al. (2008) Variations in DNA elucidate molecular networks that cause disease. Nature, 452, 429-435.
33. Dennis, G. Jr, Sherman, B.T., Hosack, D.A., Yang, J., Gao, W., Lane, H.C. and Lempicki, R.A. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol., 4,3.
34. Yang, X., Deignan, J.L., Qi, H., Zhu, J., Qian, S., Zhong, J., Torosyan, G., Majid, S., Falkard, B., Kleinhanz, R.R. et al. (2009) Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat. Genet., 41, 415-423.
35. Bensinger, S.J. and Tontonoz, P. (2008) Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature, 454, 470-477.
36. de Luca, C. and Olefsky, J.M. (2008) Inflammation and insulin resistance. FEBS Lett., 582, 97-105.
37. Karalis, K.P., Giannogonas, P., Kodela, E., Koutmani, Y., Zoumakis, M. and Teli, T. (2009) Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J., 276, 5747-5754.
38. Tilg, H. and Moschen, A.R. (2008) Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med., 14, 222-231.
39. Tilg, H. and Moschen, A.R. (2008) Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol. Metab., 19, 371-379.
40. Wheatcroft, S.B., Kearney, M.T., Shah, A.M., Ezzat, V.A., Miell, J.R., Modo, M., Williams, S.C., Cawthorn, W.P., Medina-Gomez, G., Vidal-Puig, A. et al. (2007) IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes, 56, 285-294.
41. Heald, A.H., Kaushal, K., Siddals, K.W., Rudenski, A.S., Anderson, S.G. and Gibson, J.M. (2006) Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Exp. Clin. Endocrinol. Diabetes, 114, 371-376.
42. Grarup, N., Rose, C.S., Andersson, E.A., Andersen, G., Nielsen, A.L., Albrechtsen, A., Clausen, J.O., Rasmussen, S.S., Jorgensen, T., Sandbaek, A. et al. (2007) Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes, 56, 3105-3111.
43. Lyon, H.N., Emilsson, V., Hinney, A., Heid, I.M., Lasky-Su, J., Zhu, X., Thorleifsson, G., Gunnarsdottir, S., Walters, G.B., Thorsteinsdottir, U. et al. (2007) The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet., 3, e61.
44. Norris, J.M., Langefeld, C.D., Talbert, M.E., Wing, M.R., Haritunians, T., Fingerlin, T.E., Hanley, A.J., Ziegler, J.T., Taylor, K.D., Haffner, S.M. et al. (2009) Genome-wide association study and follow-up analysis of adiposity traits in hispanic Americans: The IRAS Family Study. Obesity (Silver Spring), 17, 1932-1941.
45. Salopuro, T., Pulkkinen, L., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Tuomilehto, J., Laakso, M. et al. (2005) Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study. Int. J. Obes. (Lond.), 29, 1245-1251.
46. Wong, R.H., Chang, I., Hudak, C.S., Hyun, S., Kwan, H.Y. and Sul, H.S. (2009) A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell, 136, 1056-1072.
47. Wang, S., Yehya, N., Schadt, E.E., Wang, H., Drake, T.A. and Lusis, A.J. (2006) Genetic and genomic analysis of a fat mass trait with complex inheritance reveals marked sex specificity. PLoS Genet., 2, e15.
48. Yang, X., Schadt, E.E., Wang, S., Wang, H., Arnold, A.P., Ingram-Drake, L., Drake, T.A. and Lusis, A.J. (2006) Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res., 16, 995-1004.
49. van Nas, A., Guhathakurta, D., Wang, S.S., Yehya, N., Horvath, S., Zhang, B., Ingram-Drake, L., Chaudhuri, G., Schadt, E.E., Drake, T.A. et al. (2009) Elucidating the role of gonadal hormones in sexually dimorphic gene coexpression networks. Endocrinology, 150, 1235-1249.
50. Wang, S.S., Schadt, E.E., Wang, H., Wang, X., Ingram-Drake, L., Shi, W., Drake, T.A. and Lusis, A.J. (2007) Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data. Circ. Res., 101, e11-e30.
51. Ghazalpour, A., Doss, S., Zhang, B., Wang, S., Plaisier, C., Castellanos, R., Brozell, A., Schadt, E.E., Drake, T.A., Lusis, A.J. et al. (2006) Integrating genetic and network analysis to characterize genes related to mouse weight. PLoS Genet., 2, e130.
52. Zhang, B. and Horvath, S. (2005) A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol., 4, Article 17.
53. Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B. and Ideker, T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res., 13, 2498-2504.